We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hospital Volume Not Best Indicator of Bypass Quality

By HospiMedica staff writers
Posted on 27 Jan 2004
A study has found that for patients undergoing coronary artery bypass graft (CABG) surgery, hospital volume may not be an adequate indicator of quality, contrary to some recent recommendations. More...
The finding was reported in the January 14, 2004, issue of The Journal of the American Medical Association (JAMA).

Researchers found that the median annual hospital volume for isolated CABG procedures was 253, with 82% of centers performing fewer than 500 procedures per year and an overall mortality rate of 2.66%. After adjusting for patient risk and clustering effects, mortality rates decrease with increasing hospital volume but this association was not observed in patients younger than 65 or in those at low operative risk and was confounded by surgeon volume. Closure of up to 100 of the lowest-volume hospitals was estimated to avert less than 1% of deaths from bypass surgery.

"We found that, compared with high-volume hospitals, low-folume hospitals tended to operate on patients with higher risk and under more emergent conditions,” the authors write. "Hospital volume has generally poor predictive accuracy as a means of identifying hospitals with significantly better or worse CABG mortality rates. Using volume as a sole referral criterion for selecting a provider would unfairly defer cases from nearly half of very-low volume centers with outcomes equal or better than overall mortality results.”

The study suggests that hospital CABG surgery volume is best considered as a surrogate for quality in a setting where other more-direct process and outcome assessments are not available, conclude the researchers. The study, involving 267,089 procedures at 439 U.S. hospitals, was conducted by Eric D. Peterson, M.D., Ph.D., and colleagues at the Duke Clinical Research Institute (Durham, NC, USA).




Related Links:
Duke Clinical Research Institute

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.